Search database
Filter
5
Filtered Results: 5
Text search: Mannino, D.M.
Featured
Language
Document type
Studies & Reports
3
Guidelines
1
Strategic & Response Plan
1
Countries / Regions
Global
2
Chile
1
Latin America and the Carribbean
1
Africa
1
Authors & Publishers
et al.
2
Acta Scientific Medical Sciences​
1
Breathe, part of the European Respiratory Society (ERS)​
1
Cooper, P. J.
1
European Respiratory Journal (ERJ)
1
Figueiredo, C. A.
1
Ho T., Cusack R.P., Chaudhary N. et al.
1
Hole, D.
1
Magitta, N.F.
1
Mannino, D.M.
1
Ministerio de Salud, Gobierno de Chile
1
Rodriguez, A.
1
Sciences, A.
1
Watt, G.
1
Publication Years
Category
Public Health
4
Countries
1
Toolboxes
NCDs
4
The article from the European Respiratory Journal discusses the natural history of chronic obstructive pulmonary disease (COPD), emphasizing its increasing global impact on morbidity and mortality. It highlights that while cigarette smoking is a primary risk factor, other influences such as environm... more
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ... more
Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r... more
Resumen Ejecutivo

Under- and over-diagnosis of COPD: a global perspective

Ho T., Cusack R.P., Chaudhary N. et al. Breathe, part of the European Respiratory Society (ERS)​ (2019) CC2
The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulmonary disease (COPD) and issues related to its misdiagnosis. It highlights that COPD is under-diagnosed due to factors such as limited access to spiromet... more